In this installment in our series about diseases preventable by vaccination, we examine hepatitis A and why protection from ...
A patient in China with hepatocellular carcinoma survived 171 days following xenotransplantation with a genetically modified ...
A 56-year-old man with liver failure has become the first living person to be surgically connected to a genetically modified ...
A Winnipeg doctor says the province's response to hepatitis A has been muted, as nearly 400 cases of the acute liver ...
Gyre Therapeutics, Inc. (Gyre or Gyre Therapeutics) (Nasdaq: GYRE), a San Diego-based innovative commercial stage biopharmaceutical company with operations in the United States and China, today ...
Campylobacter hepaticus is the causative agent of spotty liver disease, resulting in mortality and production loss in laying hens. The disease is primarily associated with free range laying birds and ...
Kaposi sarcoma-associated herpesvirus testing is not routinely performed on donors or reci ...
Researchers at the University of São Paulo (USP) in Brazil have discovered a set of genes that can predict how viral ...
The search for long COVID treatments continues, as a randomized clinical trial found that a two-week course of metformin or ursodeoxycholic acid (UDCA) did not meaningfully improve recovery from ...
Hepatitis B is one of the most widespread viral infections in the world, with hundreds of millions of people living with it today. Caused by the hepatitis B virus (HBV), this condition primarily ...